Research graph
References from Antibody responses to Japanese encephalitis virus and dengue virus serotype 2 in children from an orthoflavivirus endemic region after IMOJEV vaccination. Local targets link to admitted publications; unresolved targets remain external evidence.
Flaviviridae.
2013 · External reference
Phylogenetic relationships of flaviviruses correlate with their epidemiology, disease association and biogeography
10.1099/0022-1317-82-8-1867 · 2001 · External reference
Economic cost and burden of dengue in the Philippines
10.4269/ajtmh.14-0139 · 2015 · External reference
Epidemiology of Japanese encephalitis in the Philippines: a systematic review
10.1371/journal.pntd.0003630 · 2015 · External reference
Serological Evidence of Widespread Zika Transmission across the Philippines
10.3390/v13081441 · 2021 · External reference
Pathobiology of Japanese encephalitis virus infection
10.1016/j.mam.2021.100994 · 2021 · External reference
Japanese Encephalitis: Risk of Emergence in the United States and the Resulting Impact
10.3390/v16010054 · 2023 · External reference
Japanese Encephalitis Vaccine Acceptance and Strategies for Travelers: Insights from a Scoping Review and Practitioners in Endemic Countries
10.3390/vaccines11111683 · 2023 · External reference
Current recommendations for the Japanese encephalitis vaccine
10.1016/j.jcma.2014.12.009 · 2015 · External reference
Japanese Encephalitis Surveillance and Immunization - Asia and Western Pacific Regions, 2016
10.15585/mmwr.mm6622a3 · 2017 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Dengue infection
10.1038/nrdp.2016.55 · 2016 · External reference
Unresolved reference
2023 · External reference
The Protective Role of Maternal Immunization in Early Life
10.3389/fped.2021.638871 · 2021 · External reference
Maternal Antibodies Inhibit Neonatal and Infant Responses to Vaccination by Shaping the Early-Life B Cell Repertoire within Germinal Centers
10.1016/j.celrep.2019.07.047 · 2019 · External reference
The Effect of Maternal Pertussis Immunization on Infant Vaccine Responses to a Booster Pertussis-Containing Vaccine in Vietnam
10.1093/cid/ciw551 · 2016 · External reference
Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis
10.1016/s1473-3099(19)30396-2 · 2019 · External reference
The effect of Plasmodium falciparum exposure and maternal anti-circumsporozoite protein antibodies on responses to RTS,S/AS01E vaccination in infants and children: an ancillary observational immunological study to a phase 3, randomised clinical trial
10.1016/s1473-3099(24)00527-9 · 2025 · External reference
Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants
10.1016/s0264-410x(03)00342-6 · 2003 · External reference
Unresolved reference
External reference
Cross-Reactive Immunity Among Flaviviruses
10.3389/fimmu.2020.00334 · 2020 · External reference
The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design
10.15252/embr.201745302 · 2018 · External reference
Dengue Antibody-Dependent Enhancement: Knowns and Unknowns
10.1128/microbiolspec.aid-0022-2014 · 2014 · External reference
Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age
10.1016/j.vaccine.2017.09.089 · 2017 · External reference
“I was terrified for my child”: understanding the link between the Dengvaxia® controversy and the measles vaccine hesitancy in Pasay City, Philippines
10.1093/pubmed/fdad091 · 2023 · External reference
Fear, mistrust, and vaccine hesitancy: Narratives of the dengue vaccine controversy in the Philippines
10.1016/j.vaccine.2021.07.051 · 2021 · External reference
Implications of information heard about Dengvaxia on Filipinos’ perception on vaccination
10.1016/j.vaccine.2024.01.097 · 2024 · External reference
Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness
10.1080/21645515.2018.1522468 · 2019 · External reference
Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection
10.1038/s41467-024-45806-x · 2024 · External reference
Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand
10.1371/journal.pntd.0001311 · 2011 · External reference
Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults
10.1186/s12879-016-1873-8 · 2016 · External reference
Absence of dengue 2 infection enhancement in human sera containing Japanese encephalitis antibodies
10.4269/ajtmh.1984.33.288 · 1984 · External reference
Protection against Japanese encephalitis by inactivated vaccines
10.1056/nejm198809083191004 · 1988 · External reference
Epidemiology and risk factors of Japanese encephalitis in Taiwan, 2010-2022
2023 · External reference
Seroepidemiological study of Japanese encephalitis virus in Chiang Mai: Immunity and susceptibility 28 years after introduction of a vaccination programme
10.1371/journal.pntd.0010674 · 2022 · External reference
IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine
10.1586/erv.10.139 · 2010 · External reference
Protective Role of NS1-Specific Antibodies in the Immune Response to Dengue Virus Through Antibody-Dependent Cellular Cytotoxicity
10.1093/infdis/jiae137 · 2024 · External reference
The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection
10.1016/j.chom.2007.03.002 · 2007 · External reference
Pseudo-infectious Reporter Virus Particles for Measuring Antibody-Mediated Neutralization and Enhancement of Dengue Virus Infection.
2014 · External reference
Maternal antibody and viral factors in the pathogenesis of dengue virus in infants
10.1086/519170 · 2007 · External reference
Decay and persistence of maternal dengue antibodies among infants in Bangkok
10.4269/ajtmh.2011.11-0125 · 2011 · External reference
The complexity of antibody-dependent enhancement of dengue virus infection
10.3390/v2122649 · 2010 · External reference
Role of pre-existing immunity in driving the dengue virus serotype 2 genotype shift in the Philippines: A retrospective analysis of serological data
10.1016/j.ijid.2023.11.025 · 2024 · External reference
Unresolved reference
External reference
Incidence of Dengue Virus Infection in Adults and Children in a Prospective Longitudinal Cohort in the Philippines
10.1371/journal.pntd.0004337 · 2016 · External reference
Laboratory evaluation of ELISA and indirect immunofluorescence assay in response to emergence of Japanese encephalitis virus genotype IV in Australia
10.1016/j.jcv.2023.105580 · 2023 · External reference
Comparison of four serological tests for detecting antibodies to Japanese encephalitis virus after vaccination in children
10.1016/j.phrp.2014.08.003 · 2014 · External reference
Evaluation of serological diagnostic test systems assessing the immune response to Japanese encephalitis vaccination
10.1371/journal.pntd.0000883 · 2010 · External reference
Persistence of IgM Antibodies after Vaccination with Live Attenuated Japanese Encephalitis Vaccine
10.4269/ajtmh.20-1132 · 2020 · External reference
Maternally derived antibody titer dynamics and risk of hospitalized infant dengue disease
10.1073/pnas.2308221120 · 2023 · External reference
Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes
10.1371/journal.pone.0027252 · 2011 · External reference
Simultaneous quantitation of neutralizing antibodies against all four dengue virus serotypes using optimized reporter virus particles
10.1128/jvi.00681-24 · 2024 · External reference
Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004
10.1016/j.vaccine.2005.07.002 · 2005 · External reference
Safety and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®) in children
10.1586/14760584.2016.1123097 · 2016 · External reference
Immunogenicity and safety of a single dose of a live attenuated Japanese encephalitis chimeric virus vaccine in Vietnam: A single-arm, single-center study
10.1016/j.ijid.2017.10.010 · 2018 · External reference
Original antigenic sin: A comprehensive review
10.1016/j.jaut.2017.04.008 · 2017 · External reference
Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination
10.1038/s41541-019-0133-5 · 2019 · External reference
The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines
10.3390/v12050520 · 2020 · External reference
The suitability of yellow fever and Japanese encephalitis vaccines for immunization against West Nile virus
10.1016/j.vaccine.2005.04.036 · 2005 · External reference
A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans
10.1093/infdis/jir122 · 2011 · External reference
Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection
10.3390/vaccines10091411 · 2022 · External reference
Cross-protection induced by Japanese encephalitis vaccines against different genotypes of Dengue viruses in mice
10.1038/srep19953 · 2016 · External reference
Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever
10.4269/ajtmh.1989.40.444 · 1989 · External reference
